Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar;16(3):373.
doi: 10.1007/s11912-013-0373-x.

Nonsurgical treatment for localized hepatocellular carcinoma

Andrew S Kennedy  1 , Bruno Sangro
Affiliations
Review

Nonsurgical treatment for localized hepatocellular carcinoma

Andrew S Kennedy et al. Curr Oncol Rep. 2014 Mar.

Abstract

The most common non-surgical approaches for the treatment of localized hepatocellular carcinoma remain hepatic artery-delivered particles laden with chemotherapy (TACE), or radioactive microparticles (TARE). External beam radiotherapy has been an effective option in many parts of the world for selected HCC patients, but now has an expanded role with stereotactic and proton beam technologies. This review focuses on existing evidence and current guidance for utilizing these modalities for localized, but unresectable, non-transplantable HCC patients.x.

PubMed Disclaimer

Conflict of interest statement

Andrew S. Kennedy has received honoraria from Sirtex Medical and has received travel/accommodations expenses covered or reimbursed by Sirtex Medical.

Bruno Sangro has held board membership and acted as a consultant for from Sirtex Medical and Bayer Healthcare; has received payment for development of educational presentations from Sirtex Medical and Bayer Healthcare; and has received travel/accommodations expenses covered or reimbursed by Sirtex Medical and Bayer Healthcare.

References

    1. Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi: 10.3322/caac.20107. - DOI - PubMed
    1. Center MM, Jemal A. International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2011;20(11):2362–2368. doi: 10.1158/1055-9965.EPI-11-0643. - DOI - PubMed
    1. Villanueva A, Hernandez-Gea V, Llovet JM. Medical therapies for hepatocellular carcinoma: a critical view of the evidence. Nat Rev Gastroenterol Hepatol. 2013;10(1):34–42. doi: 10.1038/nrgastro.2012.199. - DOI - PubMed
    1. Bilbao JI, et al. Comparative study of four different spherical embolic particles in an animal model: a morphologic and histologic evaluation. J Vasc Interv Radiol. 2008;19(11):1625–1638. doi: 10.1016/j.jvir.2008.07.014. - DOI - PubMed
    1. Chang JM, et al. Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study. Cancer. 1994;74(9):2449–2453. doi: 10.1002/1097-0142(19941101)74:9<2449::AID-CNCR2820740910>3.0.CO;2-4. - DOI - PubMed

MeSH terms

Substances